Removing APOE4 from microglia restores the response to chronic neurodegeneration and lessens AD pathology in both PS19-tau transgenic mice and APP/PS1 mice, highlighting the critical role of microglial APOE in AD (Liu et al., 2023a; Yin et al., 2023). The gene discussed is APP; the disease is Alzheimer disease.